Insight Molecular Diagnostics Inc. (IMDX) vs LENZ Therapeutics, Inc. (LENZ)
A side-by-side comparison of Insight Molecular Diagnostics Inc. and LENZ Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMDX
Insight Molecular Diagnostics Inc.
$3.49HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
LENZ
LENZ Therapeutics, Inc.
$3.74HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — IMDX vs LENZ
growth of $100 · dividends reinvested · last 5yIMDX -96.6% (-49.3%/yr)LENZ -91.4% (-38.7%/yr)LENZ compounded faster over this window
IMDX LENZ
IMDX vs LENZ: by the numbers
- •LENZ is the larger company ($117M vs $113M market cap).
- •Both run net losses; LENZ's is the smaller (-586.74% vs -2955.63% net margin).
Metrics side by side
Valuation
| Metric | IMDX | LENZ |
|---|---|---|
| P/S ratio | 67.48 | 5.46 |
| P/B ratio | N/A | 0.54 |
Profitability
| Metric | IMDX | LENZ |
|---|---|---|
| Gross margin | 11.17% | 90.14% |
| Operating margin | -754.08% | -477.46% |
| Net margin | -2955.63% | -586.74% |
| ROE | N/A | -57.47% |
| ROIC | -223.06% | -61.84% |
Growth (annualized)
| Metric | IMDX | LENZ |
|---|---|---|
| Revenue CAGR (5Y) | 27.24% | N/A |
| Total return CAGR (5Y) | -44.39% | -35.49% |
Frequently asked
- How have IMDX and LENZ total returns compared?
- Over the past 5 years, IMDX delivered -44.39% and LENZ delivered -35.49% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Insight Molecular Diagnostics ROELENZ Therapeutics ROEInsight Molecular Diagnostics operating marginLENZ Therapeutics operating marginInsight Molecular Diagnostics revenue growthLENZ Therapeutics revenue growthInsight Molecular Diagnostics free cash flowLENZ Therapeutics free cash flow
Insight Molecular Diagnostics & LENZ Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.